In an era of precision medicine, it is important to identify the main phenotypes in order to customise therapy in a personalised approach . A variety of proposed anti-viral, anti-inflammatory, anticoagulant and anti-fibrotic strategies may be beneficial or harmful depending on the state of disease. Recognition of different phenotypes of SARS-CoV-2 is therefore critical to clinicians and researchers for timely, effective and safe therapeutic interventions.
- Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
- Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial